Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof

Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof

US Patent 8303957 · Granted Nov 6, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Transgenic mice having a human major histocompatibility complex (MHC) phenotype,2018
Truncated CD20 protein, deltaCD202016
Truncated CD20 protein, deltaCD202014
Lentiviral vectors for the preparation of immunotherapeutical compositions2014
Use of triplex structure DNA in transferring nucleotide sequences2013
Use of triplex structure DNA in transferring nucleotide sequences2013
Use of triplex structure DNA in transferring nucleotide sequences2013
Lentiviral vectors for the preparation of immunotherapeutical compositions2013
Use of triplex structure DNA in transferring nucleotide sequences2011
Lentiviral vectors for the preparation of immunotherapeutical compositions2011
Transgenic mice having a human major histocompatability complex (MHC) phenotype,2010
Mutated immunogenic peptides derived from R9M, polynucleotides coding for same a2009